{
  "ptid_time": "010_S_4442_2012-02-07",
  "img_path": "/data/qiuhui/data/adni/images/010_S_4442/2012-02-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 12,545 mm³, 55.3% below the reference mean. With a Z-score of -1.27 (10.3th percentile), this represents mild atrophy; hippocampal volume measures 7,310 mm³, 2.7% above the reference mean. With a Z-score of 0.25 (59.9th percentile), this represents normal volume ; whole brain volume measures 1,018,970 mm³, 4.5% above the reference mean. With a Z-score of 0.57 (71.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,344 mm³, 9.0% below the reference mean. With a Z-score of -0.55 (29.1th percentile), this represents normal volume ; fusiform gyrus volume measures 17,629 mm³, 3.6% above the reference mean. With a Z-score of 0.33 (62.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,881 mm³, 6.7% below the reference mean. With a Z-score of -0.58 (28.0th percentile), this represents normal volume . ",
  "text_data": "Age is 74.2 years. Gender is Female. Education: 17 years. MMSE: 30.0. MoCA: 25.0. Logical Memory: 18.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 425.60 pg/mL (moderate reduced); Total tau: 440.20 pg/mL (significant elevated); Phosphorylated tau: 51.24 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain imaging shows mild ventricular atrophy but otherwise normal volumes in key regions like the hippocampus, entorhinal cortex, and temporal lobes. However, the CSF biomarkers (Aβ reduction, elevated T-tau and P-tau) strongly suggest Alzheimer's pathology. The MMSE is normal (30/30), but the MoCA (25/30) indicates subtle cognitive impairment, consistent with early-stage changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology).  \n\n**Confidence:** **High** (due to biomarker evidence despite relatively preserved structural volumes and borderline MoCA).  \n\n*Note: The discrepancy between imaging (mild atrophy) and biomarkers (strong AD signature) suggests early AD-related MCI, where cognitive symptoms may precede significant structural damage.*",
  "timestamp": "2025-07-25T22:35:39.627307"
}